135 related articles for article (PubMed ID: 11499819)
1. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy.
Singh M; Edwards WD; Holmes DR; Tajil AJ; Nishimura RA
Mayo Clin Proc; 2001 Aug; 76(8):799-802. PubMed ID: 11499819
[TBL] [Abstract][Full Text] [Related]
2. Descending septal branch of right coronary artery: Rare, but important in hypertrophic cardiomyopathy.
Chatterjee A; Oates ET; Leesar MA; Alli OO
Cardiovasc Revasc Med; 2017 Sep; 18(6S1):23-25. PubMed ID: 28365416
[TBL] [Abstract][Full Text] [Related]
3. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
4. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy.
Oto A; Aytemir K; Okutucu S; Kaya EB; Deniz A; Cil B; Peynircioglu B; Kabakci G
J Interv Cardiol; 2011 Feb; 24(1):77-84. PubMed ID: 20973822
[TBL] [Abstract][Full Text] [Related]
5. Alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in patients with prior coronary revascularization.
Khouzam RN; Naidu SS
J Invasive Cardiol; 2010 Dec; 22(12):E220-4. PubMed ID: 21127375
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fiber diameter and regional distribution in the ventricular wall of normal adult hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy.
Hoshino T; Fujiwara H; Kawai C; Hamashima Y
Circulation; 1983 May; 67(5):1109-16. PubMed ID: 6682019
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal septal myocardial ablation performed via the right coronary artery rather than the left anterior descending artery for the treatment of hypertrophic obstructive cardiomyopathy.
Takagi K; Mukawa H; Morishima I; Uesugi M; Okumura Y; Tsuboi H; Sone T
Int J Cardiol; 2013 Jan; 162(3):e51-2. PubMed ID: 22981456
[No Abstract] [Full Text] [Related]
8. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
9. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Jaber WA; Yang EH; Nishimura RA; Sorajja P; Rihal CS; Elesber A; Eeckhout E; Lerman A
Heart; 2009 Apr; 95(7):564-9. PubMed ID: 18952634
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy.
Sherrrid MV; Mahenthiran J; Casteneda V; Fincke R; Gasser M; Barac I; Thayaparan R; Chaudhry FA
Am J Cardiol; 2006 Jan; 97(1):106-12. PubMed ID: 16377293
[TBL] [Abstract][Full Text] [Related]
12. A repeat alcohol septal ablation procedure for hypertrophic obstructive cardiomyopathy where the first septal branch arose from the intermediate (ramus) artery.
Doran GC; Burns CM; Murdoch DJ; Incani A; Walters DL
Heart Lung Circ; 2013 Dec; 22(12):1026-9. PubMed ID: 23706939
[TBL] [Abstract][Full Text] [Related]
13. Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: are all etiologies identical?
Ganame J; Pignatelli RH; Eidem BW; Claus P; D'hooge J; McMahon CJ; Buyse G; Towbin JA; Ayres NA; Mertens L
Eur J Echocardiogr; 2008 Nov; 9(6):784-90. PubMed ID: 18490283
[TBL] [Abstract][Full Text] [Related]
14. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
[TBL] [Abstract][Full Text] [Related]
15. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
Oto A; Aytemir K; Deniz A
Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960
[TBL] [Abstract][Full Text] [Related]
16. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
[TBL] [Abstract][Full Text] [Related]
17. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
[TBL] [Abstract][Full Text] [Related]
18. The relation between His bundle and the first septal perforating artery: implications for percutaneous transluminal septal myocardial ablation.
Cui W; Liu F; Zu X; Du J; Hao Y; Li Y; Li B; Wu J
Int J Cardiol; 2004 Dec; 97(3):579-80. PubMed ID: 15561357
[TBL] [Abstract][Full Text] [Related]
19. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.
Kwon DH; Smedira NG; Rodriguez ER; Tan C; Setser R; Thamilarasan M; Lytle BW; Lever HM; Desai MY
J Am Coll Cardiol; 2009 Jul; 54(3):242-9. PubMed ID: 19589437
[TBL] [Abstract][Full Text] [Related]
20. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
